SCHEMBL5739280

SCHEMBL5739280

CCOC(Cc1cccc(-c2cccc(OCCc3nc(-c4ccccc4)oc3C)c2)c1)C(=O)O

nearest known ligand 0.70

Predicted protein targets (top 3)

geneUniProtsupporting neighboursconfidence
PPARG P37231 20/20 0.70
PPARA Q07869 15/20 0.70
PPARD Q03181 5/20 0.66

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL10211509 0.88 PPARG (0.82) PPARGPPARAPPARD
SCHEMBL3531847 0.86 PPARG (0.79) PPARGPPARAPPARD
SCHEMBL3531846 0.86 PPARG (0.79) PPARGPPARAPPARD
SCHEMBL3531849 0.86 PPARG (0.79) PPARGPPARAPPARD
SCHEMBL6317006 0.85 PPARG (0.69) PPARGPPARAPPARD
SCHEMBL5760435 0.85 PPARG (0.77) PPARGPPARAPPARD
SCHEMBL5758046 0.85 PPARG (0.74) PPARGPPARAPPARD
SCHEMBL5759748 0.85 PPARG (0.77) PPARGPPARAPPARD
SCHEMBL5759786 0.85 PPARG (0.74) PPARGPPARAPPARD
SCHEMBL5758042 0.85 PPARG (0.74) PPARGPPARAPPARD

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1615899-A1 ALPHA-SUBSTITUTED CARBOXYLIC ACIDS AS PPAR MODULATORS PFIZER INC. (US) 2006-01-18 EP claimed
WO-2004092145-A1 ALPHA SUBSTITUTED CARBOXYLIC ACID AS PPAR MODULATORS PFIZER INC. (US) 2004-10-28 WO claimed
US-20050234066-A1 Alpha substituted carboxylic acids AGOURON PHARMACEUTICALS, INC. 2005-10-20 US disclosed
US-20050187266-A1 Alpha substituted carboxylic acids PFIZER INC 2005-08-25 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20050234066-A1 Alpha substituted carboxylic acids PPARG, PPARA, PPARD PPARG 1/4885PPARA 2/4885PPARD 3/4885
US-20050187266-A1 Alpha substituted carboxylic acids PPARG, PPARA, PPARD PPARG 1/4885PPARA 2/4885PPARD 3/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.